CVS250103P75000
- 0.00
- 0.000.00%
CVS Health Newsroom
Market Whales and Their Recent Bets on CVS Options
8 Health Care Stocks Whale Activity In Today's Session
Evercore Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $60
Evercore ISI Reaffirms Their Buy Rating on CVS Health (CVS)
TD Cowen Downgrades CVS Health(CVS.US) to Hold Rating, Maintains Target Price $80
TD Cowen Remains a Hold on CVS Health (CVS)
CVS Health (CVS) Stock Moves -0.09%: What You Should Know
Under the Radar: Undervalued Assets Wall Street Isn't Talking About
Zydus Announces Agreement With CVS Caremark to Add Zituvio and Combination Products to Its Template Formulary
Express News | Zydus Announces Agreement With CVS Caremark to Add Zituvio™, Zituvimet™ and Zituvimet™ Xr (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to Its Template Formulary
Should Walgreens Stock Be in Your Portfolio Before Q1 Earnings?
BofA Securities Maintains CVS Health(CVS.US) With Buy Rating, Maintains Target Price $63
CVS Health, Aetna Grant $750,000 to Organizations Improving Health Outcomes in Illinois
Breaking Down CVS Health: 14 Analysts Share Their Views
CVS Health Options Spot-On: On January 6th, 128.46K Contracts Were Traded, With 898.05K Open Interest
On January 6th ET, $CVS Health(CVS.US)$ had active options trading, with a total trading volume of 128.46K options for the day, of which put options accounted for 45.37% of the total transactions,
Recent Dividend Declarations
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Is CVS Health Corporation (NYSE:CVS) the Best January Dividend Stock to Buy?
CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?
Truist Financial Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $60